279 related articles for article (PubMed ID: 16503855)
21. Disparity of sensitivities in detection of radiation-naïve and postirradiation recurrent nasopharyngeal carcinoma of the undifferentiated type by quantitative analysis of circulating Epstein-Barr virus DNA1,2.
Leung SF; Lo YM; Chan AT; To KF; To E; Chan LY; Zee B; Huang DP; Johnson PJ
Clin Cancer Res; 2003 Aug; 9(9):3431-4. PubMed ID: 12960133
[TBL] [Abstract][Full Text] [Related]
22. Long-term prognostic effects of plasma epstein-barr virus DNA by minor groove binder-probe real-time quantitative PCR on nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy.
Lin JC; Wang WY; Liang WM; Chou HY; Jan JS; Jiang RS; Wang JY; Twu CW; Liang KL; Chao J; Shen WC
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1342-8. PubMed ID: 17449194
[TBL] [Abstract][Full Text] [Related]
23. Treatment for metastatic nasopharyngeal carcinoma.
Bensouda Y; Kaikani W; Ahbeddou N; Rahhali R; Jabri M; Mrabti H; Boussen H; Errihani H
Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Apr; 128(2):79-85. PubMed ID: 21177151
[TBL] [Abstract][Full Text] [Related]
24. Expression of syndecan-1 (CD138) in nasopharyngeal carcinoma is correlated with advanced stage and poor prognosis.
Chen CL; Ou DL
Hum Pathol; 2006 Oct; 37(10):1279-85. PubMed ID: 16949936
[TBL] [Abstract][Full Text] [Related]
25. Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: Subgroup analysis of two Phase III trials.
Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Au GK; Min HQ
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1300-6. PubMed ID: 16750333
[TBL] [Abstract][Full Text] [Related]
26. Radiation and chemotherapy combination for nasopharyngeal carcinoma in children: Radiotherapy dose adaptation after chemotherapy response to minimize late effects.
Orbach D; Brisse H; Helfre S; Klijanienko J; Bours D; Mosseri V; Rodriguez J
Pediatr Blood Cancer; 2008 Apr; 50(4):849-53. PubMed ID: 17973328
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of plasma Epstein-Barr virus DNA load as a prognostic marker for nasopharyngeal carcinoma.
Tan EL; Looi LM; Sam CK
Singapore Med J; 2006 Sep; 47(9):803-7. PubMed ID: 16924363
[TBL] [Abstract][Full Text] [Related]
28. [Nasopharyngeal carcinoma in Tunisian children: retrospective epidemiological, clinical and biological study about 48 cases].
Jmal A; Boussen H; Ghanem A; Abaza H; Gara S; Douik H; Harzallah L; Benna F; Ladgham A; Guemira F
Bull Cancer; 2005 Nov; 92(11):977-81. PubMed ID: 16316831
[TBL] [Abstract][Full Text] [Related]
29. [Correlation of DNA ploidy in fresh tumor tissues to prognosis of nasopharyngeal carcinoma].
Han F; Wang HY; Xia YF; Liu MZ; Zhao C; Lu TX
Ai Zheng; 2007 Sep; 26(9):1015-9. PubMed ID: 17927864
[TBL] [Abstract][Full Text] [Related]
30. Chemotherapy in locoregionally advanced nasopharyngeal carcinoma-a review.
Krstevska V; Stojkovski I
J BUON; 2008; 13(4):495-503. PubMed ID: 19145670
[TBL] [Abstract][Full Text] [Related]
31. [Correlation of pretreatment serum level of endostatin to posttreatment distant metastasis in patients with advanced nasopharyngeal carcinoma].
Zhao ZJ; Mo HY; Zhang CQ; Qi B; Li J; Hong MH; Mai HQ
Ai Zheng; 2007 Nov; 26(11):1243-7. PubMed ID: 17991326
[TBL] [Abstract][Full Text] [Related]
32. Effects of zinc supplementation on the survival of patients who received concomitant chemotherapy and radiotherapy for advanced nasopharyngeal carcinoma: follow-up of a double-blind randomized study with subgroup analysis.
Lin YS; Lin LC; Lin SW
Laryngoscope; 2009 Jul; 119(7):1348-52. PubMed ID: 19402154
[TBL] [Abstract][Full Text] [Related]
33. Review of nasopharyngeal carcinoma.
Jeyakumar A; Brickman TM; Jeyakumar A; Doerr T
Ear Nose Throat J; 2006 Mar; 85(3):168-70, 172-3, 184. PubMed ID: 16615599
[TBL] [Abstract][Full Text] [Related]
34. Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma.
Leung SF; Zee B; Ma BB; Hui EP; Mo F; Lai M; Chan KC; Chan LY; Kwan WH; Lo YM; Chan AT
J Clin Oncol; 2006 Dec; 24(34):5414-8. PubMed ID: 17135642
[TBL] [Abstract][Full Text] [Related]
35. Novel therapy for nasopharyngeal carcinoma--where are we.
Tsang J; Lee VH; Kwong DL
Oral Oncol; 2014 Sep; 50(9):798-801. PubMed ID: 24462373
[TBL] [Abstract][Full Text] [Related]
36. STAT3 as a therapeutic target for Epstein-Barr virus (EBV): associated nasopharyngeal carcinoma.
Ho Y; Tsao SW; Zeng M; Lui VW
Cancer Lett; 2013 Apr; 330(2):141-9. PubMed ID: 23220625
[TBL] [Abstract][Full Text] [Related]
37. Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.
Turen S; Ozyar E; Altundag K; Gullu I; Atahan IL
Cancer Invest; 2007 Aug; 25(5):315-21. PubMed ID: 17661206
[TBL] [Abstract][Full Text] [Related]
38. Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments.
Tao Q; Chan AT
Expert Rev Mol Med; 2007 May; 9(12):1-24. PubMed ID: 17477889
[TBL] [Abstract][Full Text] [Related]
39. Potential improvement of tumor control probability by induction chemotherapy for advanced nasopharyngeal carcinoma.
Lee AW; Lau KY; Hung WM; Ng WT; Lee MC; Choi CW; Chan CC; Tung R; Cheng PT; Yau TK
Radiother Oncol; 2008 May; 87(2):204-10. PubMed ID: 18329742
[TBL] [Abstract][Full Text] [Related]
40. Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma.
Lee AW; Tung SY; Chan AT; Chappell R; Fu YT; Lu TX; Tan T; Chua DT; O'sullivan B; Xu SL; Pang ES; Sze WM; Leung TW; Kwan WH; Chan PT; Liu XF; Tan EH; Sham JS; Siu L; Lau WH
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):142-51. PubMed ID: 16904519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
